166 related articles for article (PubMed ID: 27370744)
1. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.
Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK
Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744
[TBL] [Abstract][Full Text] [Related]
2. Hyperthyroidism.
Chaker L; Cooper DS; Walsh JP; Peeters RP
Lancet; 2024 Feb; 403(10428):768-780. PubMed ID: 38278171
[TBL] [Abstract][Full Text] [Related]
3. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.
Wiersinga WM; Poppe KG; Effraimidis G
Lancet Diabetes Endocrinol; 2023 Apr; 11(4):282-298. PubMed ID: 36848916
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and decision regret in patients with late-hypothyroidism after radioiodine treatment for Graves' disease.
Li Y; Yang T; Ju L; Feng Y; Chen Z; Xiang X; Zhu T; Pang H; Wang Z
Clin Endocrinol (Oxf); 2024 Jan; 100(1):87-95. PubMed ID: 37964632
[TBL] [Abstract][Full Text] [Related]
5. Treatment Modality and Risk of Heart Failure in Patients With Long-Standing Graves' Disease: A Nationwide Population-Based Cohort Study.
Song E; Kim M; Park S; Park MJ; Kim JA; Roh E; Yu JH; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
Front Endocrinol (Lausanne); 2021; 12():761782. PubMed ID: 34690936
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting remission in hyperthyroid patients after low-dose I-131 therapy: 20 years retrospective study from a tertiary care hospital.
S SY; Padma S; Sundaram PS
Ann Nucl Med; 2024 Mar; 38(3):231-237. PubMed ID: 38277114
[TBL] [Abstract][Full Text] [Related]
7. Use of a dosimetry-based RAI protocol for treatment of benign hyperthyroidism optimises response while minimising exposure to ionising radiation.
Miller C; Al-Jabri A; O'Murchada L; Mustafa M; Cooke J; Phelan N; Healy ML
Clin Endocrinol (Oxf); 2024 Jun; 100(6):585-592. PubMed ID: 38567706
[TBL] [Abstract][Full Text] [Related]
8. Thyrotoxicosis - investigation and management .
Gilbert J
Clin Med (Lond); 2017 Jun; 17(3):274-277. PubMed ID: 28572231
[TBL] [Abstract][Full Text] [Related]
9. Effect of iodine nutritional status on the recurrence of hyperthyroidism and antithyroid drug efficacy in adult patients with Graves' disease: a systemic review.
Xie Q; Zhang X; Ma J; Lu X; Zhang Y; Tong N
Front Endocrinol (Lausanne); 2023; 14():1234918. PubMed ID: 37900151
[TBL] [Abstract][Full Text] [Related]
10. Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study.
Riis T; Bonnema SJ; Brix TH; Folkestad L
Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38367342
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcaemia as the initial presentation of Graves' disease.
Kaur K; Batra N; Kadian K; Sridharan K
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35985738
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcome of Graves' Disease: A Gender Perspective.
Calissendorff J; Cramon PK; Hallengren B; Khamisi S; Lantz M; Planck T; Sjölin G; Wallin G; Holmberg M
Womens Health Rep (New Rochelle); 2023; 4(1):487-496. PubMed ID: 37818181
[TBL] [Abstract][Full Text] [Related]
13. Application of oral inorganic iodine in the treatment of Graves' disease.
Huang Y; Xu Y; Xu M; Zhao X; Chen M
Front Endocrinol (Lausanne); 2023; 14():1150036. PubMed ID: 37077352
[TBL] [Abstract][Full Text] [Related]
14.
Yan S; Li X; Yan B
Thyroid; 2023 Nov; 33(11):1380-1381. PubMed ID: 37594743
[No Abstract] [Full Text] [Related]
15. Psychiatric complications in Graves' disease.
Holmberg M; Malmgren H; Berglund PF; Johansson B; Nyström HF
Eur Thyroid J; 2024 Feb; 13(1):. PubMed ID: 38215285
[TBL] [Abstract][Full Text] [Related]
16. Hyperthyroidism incidence in a large population-based study in northeastern Italy.
Censi S; Salmaso L; Ceccato F; Manso J; Fedeli U; Saia M; Mian C
Endocr Connect; 2023 Dec; 12(12):. PubMed ID: 37855396
[TBL] [Abstract][Full Text] [Related]
17. [Anicteric cholestasis: a rare hepatic dysfunction caused by hyperthyroidism].
Khelifi D; Nacef IB; Rojbi I; Mchirgui N; Khiari K
Pan Afr Med J; 2019; 34():215. PubMed ID: 32180887
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a questionnaire to assess health-related quality-of-life in cats with hyperthyroidism.
Blunschi F; Schofield I; Muthmann S; Bauer NB; Hazuchova K
J Vet Intern Med; 2024; 38(3):1384-1407. PubMed ID: 38647174
[TBL] [Abstract][Full Text] [Related]
19. Examination of quality of life and psychiatric symptoms in childhood Graves' disease.
Yazkan Akgül G; Köprülü Ö
J Pediatr Endocrinol Metab; 2024 May; 37(5):445-450. PubMed ID: 38644701
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life among adults newly diagnosed with pulmonary tuberculosis in Lagos State, Nigeria: a prospective study.
Adebayo BI; Adejumo OA; Odusanya OO
Qual Life Res; 2024 Jan; 33(1):157-168. PubMed ID: 37672154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
